BioAge Labs Inc (BIOA)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | Dr. Dov A. GoldsteinCFO | 3.54k | 15.51k | Derivative Exercise and Retained Stock | 4.38 | 36.58k | 10.72% |
| 2026-04-01 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -8.82k | 112.51k | Derivative Exercise and Sale | 4.11 - 17.81 | 0.00 | - |
| 2026-03-02 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -7.43k | 115.42k | Derivative Exercise and Sale | 4.11 - 20.30 | - | - |
| 2026-03-01 | Dr. Dov A. GoldsteinCFO | 3.54k | 15.51k | Derivative Exercise and Retained Stock | 4.38 | 33.03k | 12.01% |
| 2026-02-02 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -7.43k | 103.90k | Derivative Exercise and Sale | 4.11 - 18.75 | 0.00 | - |
| 2026-02-01 | Dr. Dov A. GoldsteinCFO | 3.54k | 15.51k | Derivative Exercise and Retained Stock | 4.38 | 29.49k | 13.65% |
| 2026-01-16 | Dr. Dov A. GoldsteinCFO | 3.54k | 15.51k | Derivative Exercise and Retained Stock | 4.38 | 25.95k | 15.81% |
| 2026-01-13 | Dr. Dov A. GoldsteinCFO | -27.00k | 305.30k | Derivative Exercise and Sale | 8.39 - 21.08 | 22.41k | - |
| 2026-01-13 | Dr. Kristen FortneyCo-Founder, CEO, President, Treasurer, Secretary & Director | -233.11k | 4.22M | Automatic Disposition | 18.12 | 976.95k | -19.26% |
| 2026-01-02 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -7.43k | 60.02k | Derivative Exercise and Sale | 4.11 - 12.85 | 0.00 | - |
| 2025-12-09 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -18.00k | 97.74k | Derivative Exercise and Sale | 6.57 - 12.00 | 0.00 | - |
| 2025-12-04 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -68.90k | 418.74k | Derivative Exercise and Sale | 4.11 - 10.19 | 0.00 | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。